Clrb stock split

CLRB Stock Quote - Cellectar Biosciences, Inc. Common ... Mar 30, 2020 · Stock quote for Cellectar Biosciences, Inc. Common Stock Common Stock (CLRB) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Cellectar Biosciences Announces 1-for-10 Reverse Stock Split Mar 04, 2016 · MADISON, Wis., March 04, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces a 1-for-10 reverse stock split of its common CLRB Stock | Message Board | Cellectar Biosciences, Inc ... CLRB Stock Message Board for Investors. Cellectar Biosciences, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 34 CLRB Cellectar Biosciences, Inc. Stock Quote The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey. Cellectar Announces 1-for-10 Reverse Stock Split | Markets ...

The first split for CLRB took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. CLRB's second split …

Cellectar Biosciences Announces 1-for-10 Reverse Stock Split Mar 04, 2016 · MADISON, Wis., March 04, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces a 1-for-10 reverse stock split of its common CLRB Stock | Message Board | Cellectar Biosciences, Inc ... CLRB Stock Message Board for Investors. Cellectar Biosciences, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 34 CLRB Cellectar Biosciences, Inc. Stock Quote The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey. Cellectar Announces 1-for-10 Reverse Stock Split | Markets ...

CLRB - Research and Analysis for CELLECTAR BIOSCIENCES ...

CLRB Stock Quote - Cellectar Biosciences, Inc. Common ... Mar 30, 2020 · Stock quote for Cellectar Biosciences, Inc. Common Stock Common Stock (CLRB) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Cellectar Biosciences, Inc. (CLRB) Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. CLRB Price Target and Analyst Ratings (Cellectar Biosciences)

Cellectar Biosciences, Inc. (CLRB)

3 Stocks That Could Hit $1,000 An unusual milestone for a stock is $1,000 -- one that most stocks will never achieve because companies will split their shares well before the price ever comes CLRB / Cellectar Biosciences, Inc. Overview - (15117F302 ... Split History. Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. Cellectar Biosciences (NASDAQ:CLRB) Ratings | Benzinga Jan 01, 2010 · Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers

CLRB Stock Price | Cellectar Biosciences Inc. Stock Quote ...

Nov 01, 2019 · Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR … Cellectar Biosciences, Inc. (CLRB) Stock Analysis & News ... Get breaking news and analysis on Cellectar Biosciences, Inc. (CLRB) stock, price quote and chart, trading and investing tools.

Sep 06, 2019 · Their average twelve-month price target is $6.33, suggesting that the stock has a possible upside of 396.58%. The high price target for CLRB is $10.00 and the low price target for CLRB is $3.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy." Cellectar Biosciences (CLRB) Reports 1-for-10 Reverse ...